Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $48.66 and last traded at $48.61, with a volume of 114786 shares traded. The stock had previously closed at $46.70.
Analyst Ratings Changes
Several equities research analysts recently weighed in on SDZNY shares. BNP Paribas cut shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, December 2nd. UBS Group downgraded shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a research note on Monday.
View Our Latest Stock Analysis on Sandoz Group
Sandoz Group Price Performance
About Sandoz Group
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
See Also
- Five stocks we like better than Sandoz Group
- What Are Some of the Best Large-Cap Stocks to Buy?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is the Nikkei 225 index?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Conference Calls and Individual Investors
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
